Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration

被引:58
作者
Dayoub, Rania
Thasler, Wolfgang E.
Bosserhoff, Anja K.
Singer, Thomas
Jauch, Karl-Walter
Schlitt, Hans J.
Weiss, Thomas S. [1 ]
机构
[1] Univ Regensburg Hosp, Dept Surg, Regensburg, Germany
[2] Univ Regensburg Hosp, Ctr Liver Cell Res, Regensburg, Germany
[3] LM Univ Munich, Hosp Grosshadern, Dept Surg, Munich, Germany
[4] Univ Regensburg Hosp, Inst Pathol, Regensburg, Germany
[5] Hoffmann La Roche Ltd Non Clin Safety, Basel, Switzerland
关键词
liver regeneration; polyamines; ornithine decarboxylase; hepatotrophic growth factor; augmenter of liver regeneration; immediate early gene; c-myc;
D O I
10.1016/j.bbrc.2006.04.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Different stages of liver regeneration are regulated by a variety of factors Such as the liver growth associated protein ALR, augmenter of liver regeneration. Furthermore, small molecules like polyamines were proven to be essential for hepatic growth and regeneration. Therefore, using primary human hepatocytes in vitro we investigated the effect of ALR on the biosynthesis of polyamines. We demonstrated by HPLC analysis that recombinant ALR enhanced intracellular hepatic putrescine, spermidine, and spermine levels within 9-12 h. The activation of polyamine biosynthesis was dose dependent with putrescine showing the strongest increase. Additionally, ALR treatment induced mRNA expression of ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase, both key enzymes of polyamine biosynthesis. Further, ALR induced c-myc mRNA expression.. a regulator of ODC expression, and therefore we assume that ALR exerts its liver regeneration augmenting effects through stimulation of its signalling pathway leading in part to enhanced polyamine synthesis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 42 条
[1]
ABRAHAMSEN MS, POLYAMINES GASTROINT, P29
[2]
BEYER HS, 1990, BIOCHEM INT, V20, P761
[3]
BLANC P, 1992, GASTROENTEROLOGY, V102, P1340
[4]
The potentiation role of hepatopoietin on activator protein-1 is dependent on its sulfhydryl oxidase activity [J].
Chen, XX ;
Li, Y ;
Wei, KH ;
Li, L ;
Liu, WL ;
Zhu, YP ;
Qiu, ZY ;
He, FC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :49022-49030
[5]
Dang CV, 1999, MOL CELL BIOL, V19, P1
[6]
SUPPLEMENTAL PUTRESCINE REVERSES ETHANOL-ASSOCIATED INHIBITION OF LIVER-REGENERATION [J].
DIEHL, AM ;
ABDO, S ;
BROWN, N .
HEPATOLOGY, 1990, 12 (04) :633-637
[7]
Inhibition of rat hepatocyte proliferation by transforming growth factor β and glucagon is associated with inhibition of ERK2 and p70 S6 kinase [J].
Dixon, M ;
Agius, L ;
Yeaman, SJ ;
Day, CP .
HEPATOLOGY, 1999, 29 (05) :1418-1424
[8]
Donato MT, 1998, J PHARMACOL EXP THER, V284, P760
[9]
FRANCAVILLA A, 1994, HEPATOLOGY, V20, P747, DOI 10.1002/hep.1840200328
[10]
Fujiwara K, 1998, LIVER GROWTH REPAIR, P163